Variant report

Variant	rs61061587
Chromosome Location	chr14:20955160-20955161
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr14:20922313..20926325-chr14:20953415..20955959,4	MCF-7	breast:
2	chr14:20928211..20932103-chr14:20954207..20959155,7	MCF-7	breast:
3	chr14:20946456..20948319-chr14:20953863..20956686,2	MCF-7	breast:
4	chr14:20952441..20955296-chr14:20969698..20972356,2	K562	blood:
5	chr14:20943646..20946823-chr14:20952144..20956425,3	MCF-7	breast:
6	chr14:20935619..20940604-chr14:20953985..20960417,8	MCF-7	breast:

Variant related genes	Relation type
ENSG00000198805	Chromatin interaction
ENSG00000092094	Chromatin interaction
ENSG00000258908	Chromatin interaction
ENSG00000165782	Chromatin interaction
ENSG00000100823	Chromatin interaction

Extended variants
information (count: 13 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:10)

rs_ID	r²[population]
rs17113273	1.00[AMR][1000 genomes]
rs56833696	1.00[AMR][1000 genomes]
rs58988374	1.00[AMR][1000 genomes]
rs59800190	1.00[AMR][1000 genomes]
rs73583394	1.00[AMR][1000 genomes]
rs73585305	1.00[AMR][1000 genomes]
rs73585312	1.00[AMR][1000 genomes]
rs74034350	1.00[AMR][1000 genomes]
rs74037153	1.00[AMR][1000 genomes]
rs891298	1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:3 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1043923	chr14:20338742-21336425	Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	203 gene(s)	inside rSNPs	diseases
2	nsv541970	chr14:20338742-21336425	Strong transcription Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	203 gene(s)	inside rSNPs	diseases
3	esv21015	chr14:20800765-21257878	Active TSS Flanking Active TSS Enhancers Weak transcription Strong transcription Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	173 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:20940200-20957600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr14:20943400-20963200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr14:20945800-20955400	Weak transcription	Small Intestine	intestine
4	chr14:20946000-20955400	Weak transcription	Duodenum Smooth Muscle	Duodenum
5	chr14:20946000-20955400	Weak transcription	GM12878-XiMat	blood
6	chr14:20946000-20957000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
7	chr14:20946000-20957800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
8	chr14:20946400-20956400	Weak transcription	HepG2	liver
9	chr14:20946400-20957600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
10	chr14:20946600-20957600	Weak transcription	Spleen	Spleen
11	chr14:20946800-20957400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
12	chr14:20946800-20957600	Weak transcription	Hela-S3	cervix
13	chr14:20947000-20955200	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
14	chr14:20947000-20955200	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
15	chr14:20947000-20957400	Weak transcription	NHEK	skin
16	chr14:20947000-20957800	Weak transcription	Adipose Nuclei	Adipose
17	chr14:20947400-20955200	Weak transcription	Primary hematopoietic stem cells	blood
18	chr14:20947400-20957200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
19	chr14:20947400-20957400	Weak transcription	Osteobl	bone
20	chr14:20947600-20956600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
21	chr14:20947600-20956600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
22	chr14:20947600-20956800	Weak transcription	HMEC	breast
23	chr14:20947600-20958600	Weak transcription	HUVEC	blood vessel
24	chr14:20947800-20957600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr14:20948000-20956800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr14:20950000-20957600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
27	chr14:20952000-20957800	Weak transcription	Duodenum Mucosa	Duodenum
28	chr14:20953400-20955600	Enhancers	H9 Cell Line	embryonic stem cell
29	chr14:20953600-20955200	Enhancers	iPS-15b Cell Line	embryonic stem cell
30	chr14:20953600-20955400	Enhancers	ES-I3 Cell Line	embryonic stem cell
31	chr14:20953600-20957800	Enhancers	Primary T helper cells fromperipheralblood	blood
32	chr14:20953800-20955200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
33	chr14:20953800-20955200	Enhancers	Primary T helper cells PMA-I stimulated	--
34	chr14:20953800-20957600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
35	chr14:20953800-20959600	Enhancers	Primary B cells from peripheral blood	blood
36	chr14:20954000-20955200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
37	chr14:20954000-20957400	Enhancers	Primary T helper naive cells from peripheral blood	blood
38	chr14:20954000-20960000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
39	chr14:20954000-20960200	Enhancers	Primary T cells fromperipheralblood	blood
40	chr14:20954200-20955200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
41	chr14:20954200-20955200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr14:20954200-20956200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
43	chr14:20954200-20956200	Enhancers	Primary neutrophils fromperipheralblood	blood
44	chr14:20954200-20957600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
45	chr14:20954400-20967000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
46	chr14:20954600-20956400	Weak transcription	HUES48 Cell Line	embryonic stem cell
47	chr14:20954600-20957400	Weak transcription	HUES6 Cell Line	embryonic stem cell
48	chr14:20954600-20957400	Weak transcription	HUES64 Cell Line	embryonic stem cell
49	chr14:20954600-20957600	Weak transcription	H1 Cell Line	embryonic stem cell
50	chr14:20954600-20957600	Weak transcription	Lung	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links